Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03149120
Title Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York University School of Medicine
Indications

sarcoma

Therapies

Nivolumab

Nivolumab + Pazopanib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.